Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1015) Edluar (zolpidem tartrate), Orexo,
...Approved March 2009 Treatment Area: insomnia General Information Edluar (zolpidem tartrate) is a sublingual non-benzodiazepine hypnotic of the imidazopyridine class. It interacts with a GABA-BZ receptor complex, found in ...
...nervous system, by binding to gamma-aminobutyric acid (GABAA) receptors at the same location as benzodiazepines. Imidazopyridine are molecularly distinct from the classical benzodiazepine molecule and thus don't possess the ...
View Page

2.  Study Posting (3825) Trial #72109, Bipolar Disorders, Irving, TX
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

3.  Study Posting (3825) Trial #72108, Bipolar Disorders, Houston, TX
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

4.  Study Posting (3825) Trial #72106, Bipolar Disorders, Austin, TX
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

5.  Study Posting (3825) Trial #72104, Bipolar Disorders, Oklahoma City, OK
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

6.  Study Posting (3825) Trial #72102, Bipolar Disorders, Raleigh, NC
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

7.  Study Posting (3825) Trial #72110, Bipolar Disorders, Atlanta, GA
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

8.  Study Posting (3825) Trial #72112, Bipolar Disorders, San Diego, CA
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

9.  Study Posting (3825) Trial #72103, Bipolar Disorders, National City, CA
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

10.  Study Posting (3825) Trial #72113, Bipolar Disorders, Garden Grove, CA
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

11.  Study Posting (3825) Trial #72111, Bipolar Disorders, Cerritos, CA
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

12.  Study Posting (3825) Trial #72107, Bipolar Disorders, Scottsdale, AZ
...release capsules either once daily or twice daily. Patients will be allowed to continue taking benzodiazepines, lithium, valproate, olanzapine, risperidone and/or quetiapine during the study. This study is currently enrolling ...
View Page

13.  Study Posting (4971) Trial #161600, Alcohol Dependence, Maitland, FL
...drugs • The following medications are prohibited during this study: acamprosate, all anxiolytics, all antidepressants, baclofen, benzodiazepines, buprenorphine, carbamazepine, disulfiram, divalproex sodium, ethosuximide, felbamate, gabapentin, lamotrigine, levetiracetam, levomethadyl acetate (LAAM), mephobarbital, methadone ...
View Page

14.  Study Posting (3826) Trial #72121, Bipolar Disorders, Irving, TX
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page

15.  Study Posting (3826) Trial #72120, Bipolar Disorders, Houston, TX
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page

16.  Study Posting (3826) Trial #72118, Bipolar Disorders, Austin, TX
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page

17.  Study Posting (3826) Trial #72116, Bipolar Disorders, Oklahoma City, OK
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page

18.  Study Posting (3826) Trial #72114, Bipolar Disorders, Raleigh, NC
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page

19.  Study Posting (3826) Trial #72122, Bipolar Disorders, Atlanta, GA
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page

20.  Study Posting (3826) Trial #72124, Bipolar Disorders, San Diego, CA
...be added to current therapy as lamotrigine and valproate are slowly discontinued. The use of benzodiazepines during the study will also be allowed. This study is currently enrolling. Patients must meet ...
View Page